New VTE Guidelines Released
The American College of Chest Physicians (CHEST) issued some new guidelines for the treatment of venous thromboembolism (VTE).
New Indication for Pradaxa
RIDGEFIELD, Conn., November 23, 2015 – Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Pradaxa® (dabigatran etexilate mesylate) for the prophylaxis of deep venous thrombosis (DVT) and pulmonary embolism (PE) in patients who have undergone hip replacement surgery.
Spreading the Word About Thrombosis
After fracturing her ankle and getting a cast, South African athlete Marie-Victoire Cumming began feeling extreme discomfort in her leg. What she didn't know was that she had a potentially life-threatening condition called deep vein thrombosis.
When Anticoagulants Go Head-to-Head
When two medications have the same effect, a head-to-head trial is often the best way to see which one is more effective.
'Low T' and Blood Clots: A Possible Change in Thinking
Some men with low testosterone might be tempted to hold off on treatment due to concerns about raised health risks. But for one common concern, those raised risks might not exist.
What Women Need to Know About Blood Clots
Taking "the pill" has become a routine part of life for many women around the world. But that doesn't mean birth control pills are entirely without risk.
Menopause Rx: The Heart of the Matter
The use of hormones during menopause was once thought to protect against heart disease, but that may not be the case.
FDA Approves Anti-Clotting Drug Savaysa
The U.S. Food and Drug Administration today approved the anti-clotting drug Savaysa (edoxaban tablets) to reduce the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
Patients Have Power to Lower Post-Surgery Clot Risk
The risk for blood clots may go up after surgery, but patients can take steps to lower that risk.
Common Medicines May Increase Blood Clot Risk
When dealing with a headache or other pain, many people reach for over-the-counter pain relievers like naproxen or ibuprofen. But these types of medication, known as non-steroidal anti-inflammatory drugs (NSAIDS), could come with an increased risk of blood clots.